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A B S T R A C T
We report the generation of three isogenic iPSC clones (UNIBSi007-A, UNIBSi007-B, and UNIBSi007-C) obtained from ﬁbroblasts of a patient with Aicardi Goutières
Syndrome (AGS) carrying a homozygous mutation in RNaseH2B. Cells were transduced using a Sendai virus based system, delivering the human OCT4, SOX2, c-MYC
and KLF4 transcription factors. The resulting transgene-free iPSC lines retained the disease-causing DNA mutation, showed normal karyotype, expressed pluripotent
markers and could diﬀerentiate in vitro toward cells of the three embryonic germ layers.
Resource Table:
Unique stem cell lines
identiﬁer
UNIBSi007-A
UNIBSi007-B
UNIBSi007-C
Alternative names of st-
em cell lines
AGS2_MV_C3 (UNIBSi007-A)
AGS2_MV_C4 (UNIBSi007-B)
AGS2_MV_C6 (UNIBSi007-C)
Institution "Angelo Nocivelli" Institute for Molecular Medicine,
Department of Molecular and Translational Medicine,
University of Brescia, 25,123 Brescia, Italy
Contact information of
distributor
Rosalba Monica Ferraro: rosalbamonica.ferraro@
gmail.com
Type of cell lines iPSCs
Origin Human
Additional origin info Age: 10
Sex: female
Ethnicity: Caucasian
Cell Source Fibroblasts
Clonality Clonal
Method of reprogram-
ming
CytoTune™-iPS 2.0 Sendai Reprogramming Kit
(ThermoFisher Scientiﬁc). The episomal reprogramming
vectors include the four Yamanaka factors OCT4, SOX2,
KLF4, and C-MYC
Multiline rationale Isogenic clones
Gene modiﬁcation NO
Type of modiﬁcation N/A
Associated disease Aicardi Goutières syndrome
Gene/locus RNaseH2B/13q14.3
Method of modiﬁcation N/A
Name of transgene or r-
esistance
N/A
Inducible/constitutive
system
N/A
Date archived/stock da-
te
Jan-2017
Cell line repository/ba-
nk
https://hpscreg.eu/user/cellline/edit/UNIBSi007-A
https://hpscreg.eu/user/cellline/edit/UNIBSi007-B
https://hpscreg.eu/user/cellline/edit/UNIBSi007-C
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1. Resource utility
AGS is a severe monogenic inﬂammatory encephalopathy. To date,
for disease studying, knockout mouse approach is not available because
of embryonic lethality of RNaseH2–deﬁcient mice (Rabe, 2013). Thus,
iPSCs generation represents the best option to obtain patient-speciﬁc
neuronal cells for in vitro modeling of the disease.
2. Resource details
AGS is an early-onset monogenic type 1 interferonopathy, with se-
vere neurologic injury. The syndrome is caused by altered nucleic acids
metabolism due to defects in diﬀerent nucleases or nucleotidases
(Fazzi et al., 2013). Three of the six disease-causing genes identiﬁed to
date encode components of the ribonuclease H2 (RNaseH2) complex
(RNASEH2A, RNASEH2B, RNASE2HC). Among them, RNASEH2B mu-
tations accounts for AGS type 2 (Crow et al., 2006).
RNaseH2 is an hydrolase able to process the RNA strand of
RNA:DNA hybrids, and to recognize and cleave single ribonucleotides
embedded in genomic DNA. The complex is composed by RNaseH2A,
that contains the core of the catalytic domain, and by two accessory
subunits RNaseH2B and RNaseH2C. Mutation in subunit A and B are
known to have a destabilizing eﬀect on the entire RNaseH2 complex,
leading to an enzymatic function reduction (Pizzi et al., 2015).
In this study we generated and characterized three isogenic iPSC
clones (UNIBSi007-A, UNIBSi007-B, and UNIBSi007-C) derived from
ﬁbroblasts of a 10 years old female aﬀected by AGS with a homozygous
mutation in RNaseH2B:NM_024570.3:c.[529G > A, 529G > A]:p.
[A177T]; [A177T] (Table 1).
Reprogramming was performed in feeder free conditions using a
modiﬁed form of Sendai virus as episomal vector expressing the
Yamanaka's factors OCT4, SOX2, KLF4, and c-MYC (CytoTune-iPS 2.0
Sendai Reprogramming Kit).
The iPSC lines obtained displayed a round shape and growth
behavior typical of embryonic stem cell (Supplementary Fig.1).
Mycoplasma testing by PCR analysis was negative (Supplementary
Fig. 3).
We conﬁrmed by short tandem repeat (STR) proﬁling the identical
proﬁle between the iPSC lines and patient's ﬁbroblasts (Table 2), and
we also veriﬁed the presence of the homozygous mutation by Sanger
sequencing (Fig. 1A). Karyotyping was performed at diﬀerent passages,
using standard QFQ-banding showing a normal 46, XX pattern for all
selected clones (Supplementary Fig. 2).
Expression of key pluripotency markers, such as the cell membrane
protein Tra-1-60, and the transcriptional factor OCT4, was demon-
strated by immunostaining (Fig. 1B).
A deeper pluripotency characterization by TaqMan® Human
Pluripotent Stem Cell Scorecard™ analysis was performed at passage 15.
Each line showed the expected result: a positive score for self-renewal
gene expression and a negative score for expression of genes involved in
ectodermal, mesodermal, and endodermal formation. Moreover, no
residual Sendai virus was detected (Fig. 1C).
Finally, we tested the ability of iPSC clones to diﬀerentiate in vitro in
the three germ embryonic layers. The UNIBSi007-A clone, was analyzed
through TaqMan® Human Pluripotent Stem Cell Scorecard™ revealing
increased gene expression in the three germ layers and reduced in self-
renewal markers (Fig. 1D). The remaining clones, UNIBSi007-B and
UNIBSi007-C, were evaluated by quantitative PCR (qPCR) for ecto-
dermal, mesodermal and endodermal markers (PAX6-SOX1, CXCR4-
ACTA2, GATA4-SOX17, respectively) showing the expected increased
expression for all the genes (Fig. 1E).
In conclusion, we generated and characterized three isogenic iPSC
clones carrying mutations in RNaseH2B, the most frequently mutated
gene in AGS (Al Mutairi et al., 2018). These clones represents a useful
tools for disease modelling, and a step forward to the data in literature,
as to date, the description of AGS2 patient-derived-iPSCs has not been
reported yet.
Table 1.
Summary of lines.
iPSC line names Abbreviation in ﬁgures Gender Age Ethnicity Genotype of locus Disease
UNIBSi007-A UNIBSi007-A Female 10 y Caucasian A/A Aicardi Goutières Syndrome type 2 (AGS2).
UNIBSi007-B UNIBSi007-B Female 10 y Caucasian A/A Aicardi Goutières Syndrome type 2 (AGS2).
UNIBSi007-C UNIBSi007-C Female 10 y Caucasian A/A Aicardi Goutières Syndrome type 2 (AGS2).
Table 2.
Characterization and validation.
Classiﬁcation Test Result Data
Morphology Photography normal Supplementary Figure 1
Phenotype Qualitative analysis: immunocytochemistry Positive for OCT4, and TRA–1–60 expression Fig. 1 panel B
Quantitative analysis: TaqMan® Human
Pluripotent Stem Cell Scorecard™ analysis
Positive score for self-renewal gene expression and negative
score for ectodermal, mesodermal, and endodermal gene
expression
Fig. 1 panel C
Genotype Karyotype (Q-banding) and resolution 46,XX
Resolution 450–500 bands
Supplementary Figure 2
Identity Microsatellite PCR (mPCR) OR
STR analysis
N/A N/A
16 distinct loci: all matched to parental cell line Available with the
authors
Mutation analysis (IF
APPLICABLE)
Sequencing Homozygous mutation: c.[529G > A] Fig. 1 panel A
Southern Blot OR WGS N/A N/A
Microbiology and virology Mycoplasma endpoint PCR Negative Supplementary Figure 3
Diﬀerentiation potential Direct in vitro diﬀerentiation into three germ layers
UNIBSi007-A: TaqMan® hPSC Scorecard™ analysis
UNIBSi007-A: negative score for self-renewal gene
expression and positive score for trilineage gene expression
Fig. 1 panel D
UNIBSi007-B and UNIBSi007-C: qPCR with
TaqMan chemistry
UNIBSi007-B and UNIBSi007-C: induction of PAX6-SOX1
(Ectoderm), CXCR4 –ACTA2 (Mesoderm), and GATA4-
SOX17 (Endoderm).
Fig. 1 panel E
Donor screening (OPTIONAL) HIV 1++2 Hepatitis B, Hepatitis C N/A N/A
Genotype additional info
(OPTIONAL)
Blood group genotyping N/A N/A
HLA tissue typing N/A N/A
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Fig. 1. Characterization of the iPSC lines UNIBSi007-A, UNIBSi007-B, and UNIBSi007-C. (A) Electropherograms showing the homozygous mutation in RNaseH2B. (B)
Immunoﬂuorescence staining for the stemness markers Tra-1-60 (green) and Oct4 (red). Nuclei were counterstained with Hoechst33342 (blue). (C) Pluripotency
assessment using TaqManⓇ Human Pluripotent Stem Cell ScorecardTM analysis. (D) Schematic summary of TaqManⓇ Human Pluripotent Stem Cell ScorecardTM panel
depicting the in vitrotrilineage diﬀerentiation capability of UNIBSi007-A iPSC line. (E) Gene expression analysis of the three germ layers markers in UNIBSi007-B,
and UNIBSi007-C iPSC clones.
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3. Materials and methods
3.1. Fibroblasts reprogramming
Primary ﬁbroblasts, derived from AGS2 patient's skin biopsy, were
cultured in DMEM with 10% Fetal Bovine Serum, 1% L-Glutamine, and
1% Penicillin/Streptomycin (Euroclone) in standard conditions. For
iPSCs generation 105 ﬁbroblasts were transduced using the CytoTune-
iPS 2.0 Sendai Reprogramming Kit (ThermoFisher Scientiﬁc) under
manufacturer's instructions. After 8 days, cells were transferred onto a
Matrigel-coated culture dish and then cultured with Nutristem hPSC XF
medium (Biological-Industries). Colonies positive for Tra-1-60 staining,
appearing after 20 days were manually picked to further expansion and
characterization.
3.2. Karyotyping
Conventional QFQ-banding at 450 bands resolution according to the
International System for Human Cytogenetic Nomenclature (ISCN
2016) was used to perform karyotypes. A minimum of 20 metaphase for
each sample were analysed.
3.3. Sequencing
Genomic DNA was extracted using the QIAmp DNA Blood Mini Kit
(Qiagen), and ampliﬁed by PCR using AmpliTaq Gold® Taq Polymerase
(ThermoFisher Scientiﬁc) with RNaseH2B speciﬁc primers (Table 3).
Sequencing reactions were performed using BigDye Terminator v1.1
Cycle Sequencing Kit, and run on a ABI Prism 3130 Genetic Analyzer
(ThermoFisher Scientiﬁc), then analysed using SeqScape v3.0 Software
(ThermoFisher Scientiﬁc).
3.4. TaqMan hPSC scorecard assay
RNAs collected from iPSCs were sent to ThermoFisher Scientiﬁc
CellModel Service to perform TaqMan hPSC scorecard assay. This test is
designed to verify the loss of Sendai virus, and to evaluate the ex-
pression levels of genes involved in self-renewal, endodermal, meso-
dermal, and ectodermal development.
3.5. Immunoﬂuorescence staining
iPSCs were ﬁxed and permeabilized using Fix&Perm-Reagent kit
(SIC), then, blocked for 45min. with iBind™ Buﬀer solution
(Invitrogen) Slides were incubated for 3 h at room temperature (RT)
with primary antibodies and after washing, secondary antibodies were
added for 1 h at RT. The antibodies used are summarized in Table 3.
Cellular nuclei were counter stained with Hoechst 33,342 (Thermo-
Fisher Scientiﬁc). Cells were observed with an inverted ﬂuorescence
microscope (Olympus IX70), and images were analysed with the Image-
Pro-Plus software v7.0 (Media Cybernetics).
3.6. In vitro trilineage diﬀerentiation
iPSCs were dissociated into single-cell suspension and seeded on
matrigel-coated 24-well plates (105, 8× 104, 13×104 cells for ecto-
derm, mesoderm, and endoderm, respectively) in the speciﬁc medium
according to the StemMACS™ Trilineage Diﬀerentiation Kit protocol
(MACS Miltenyi Biotec). Cells were then collected 7 days later for RNA
extraction and qPCR of lineage speciﬁc markers. Only for UNIBSi006-B,
RNAs collected from each germinal layer were mixed in a 1:1:1 ratio to
perform TaqMan hPSC scorecard assay.
3.7. RNA extraction and qPCR
Total RNA was extracted using NucleoSpin® RNA II kit (Macherey-
Nagel). RNAs were retro-transcribed by ImPromII™ Reverse
Transcription System (Promega). qPCR for iPSCs diﬀerentiation was
assessed using iQ MPLX powermix and TaqMan Probe based assays.
Probes are listed in Table 3. Assays were performed on CFX96 C1000
Touch™ Real-Time PCR Detection System, and analysed with CFX
manager software v.3.1 (BioRad). The relative quantiﬁcation of target
genes was calculated by the 2^−ΔΔCt method, using βACTIN as house-
keeping gene.
3.8. Mycoplasma detection
The absence of mycoplasma contamination was conﬁrmed by PCR
using primers listed in Table 3.
Table 3.
Reagents details.
Antibodies used for immunocytochemistry
Antibody Dilution Company Cat # and RRID
Pluripotency Markers Rabbit anti-OCT4 1:400 Thermo Fisher Scientiﬁc, Cat# A-13,998. RRID: AB_2,534,182
Pluripotency Markers Mouse anti–TRA–1–60 1:100 Thermo Fisher Scientiﬁc, Cat# 4,110,000. RRID: AB_2,533,494
Secondary antibodies Goat anti rabbit IgG (H++L) Alexa Fluor 568 1:300 Thermo Fisher Scientiﬁc, Cat# A-11,011. RRID: AB_143,157
Secondary antibodies Goat anti mouse IgG (H++L) Alexa Fluor 488 1:300 Thermo Fisher Scientiﬁc, Cat# A-11,001. RRID: AB_2,534,069
Primers for PCR assay
Target Forward/Reverse primer (5′−3′)
Mutation sequencing RNaseH2B exon TAAATGGTCTGAAGGCCACC/ATGAGGCTTCTGTGATATTAAG (347 bp)
Mycoplasma detection 16 s rRNA GGGAGCAAACAGGATTAGATACCCT/TGCACCATCTGTCACTCTGTTAACCTC (268 bp)
Diﬀerentiation RT-qPCR assays with TaqMan chemistry
Target Probe
Ectoderm PAX6 Hs.PT.58.25914558
SOX1 Hs.PT.58.28041414.g
Mesoderm ACTA2 Hs.PT.56a.2542642
CXCR4 Hs00607978_s1
Endoderm GATA4 Hs.PT.58.259457
SOX17 Hs.PT.58.24876513
Housekeeping gene ACTB Hs.PT.39a.22214847
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